No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 – 75
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
40 (estimated)
Sponsor
Johns Hopkins University · Other
Who this trial is looking for
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
The purpose of this study is to examine 1) effects of cutaneous electrical trigeminal nerve stimulation (eTNS) on respiratory control in healthy volunteers and 2) explore the potential of this approach to mitigate dyspnea in patients with chronic obstructive lung disease (COPD).
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Arm1 - Healthy Volunteers
Inclusion Criteria:
* Adults aged 18-50 years
* BMI 18-30 kg/m²
* Ability to provide informed consent and complete study procedures in English
Exclusion Criteria:
* Current daytime respiratory impairment such as uncontrolled asthma, uncontrolled COPD, pneumonia, or inte…
Arm1 - Healthy Volunteers
Inclusion Criteria:
* Adults aged 18-50 years
* BMI 18-30 kg/m²
* Ability to provide informed consent and complete study procedures in English
Exclusion Criteria:
* Current daytime respiratory impairment such as uncontrolled asthma, uncontrolled COPD, pneumonia, or interstitial lung disease
* Use of supplemental oxygen
* Pregnancy or breastfeeding
* Current use of acetazolamide, Sodium-glucose cotransporter-2 (SGLT2) inhibitors, or daily opioids
* History of claustrophobia or panic disorder
* Metallic implants in the craniofacial or cervical region that may interfere with electrode placement or electrical stimulation
* Implanted cardiac or neuroelectric device (e.g., pacemaker, implantable cardioverter-defibrillator (ICD), deep brain stimulator, vagus nerve stimulator, implanted drug pump)
* Open, broken, inflamed, infected, or healing skin lesions at or near facial electrode placement sites
* Resting heart rate \<60 Beats Per Minute
* History of seizure disorder or epilepsy
Arm 2 -COPD
Inclusion Criteria:
* Adults aged 40-75 years
* Confirmed diagnosis of COPD by spirometry (post-bronchodilator Forced Expiratory Volume (FEV1) /Forced Vital Capacity (FVC) \<0.70) or provider documentation in medical records
* Modified Medical Research Council (mMRC) dyspnea grade ≥2
* Stable COPD (no exacerbation requiring hospitalization, systemic corticosteroids, or antibiotic therapy within the preceding 6 weeks)
* On stable COPD therapy for at least 4 weeks prior to enrollment
* Ability to provide informed consent and complete questionnaires in English
* Resting Peripheral Capillary Oxygen Saturation (SpO₂) ≥88% on room air or prescribed supplemental oxygen
Exclusion Criteria:
* Unstable cardiovascular disease (e.g., unstable angina, decompensated heart failure, recent MI within 6 months, uncontrolled arrhythmia) or peripheral vascular disease
* Patients with cardiovascular disease, including chest pain, heart failure, and aortic stenosis
* Resting heart rate \<60 BPM
* Implanted cardiac or neuroelectric device (e.g., pacemaker, ICD, deep brain stimulator, vagus nerve stimulator, implanted drug pump)
* Metallic implants in the craniofacial or cervical region that may interfere with electrode placement or stimulation
* Open, broken, inflamed, infected, or healing skin lesions at or near facial electrode placement sites
* Active trigeminal neuralgia or other cranial neuropathy
* History of seizure disorder or epilepsy
* Severe or uncontrolled psychiatric disorder (e.g., psychosis, severe untreated anxiety or panic disorder) that would impair the ability to participate
* Pregnancy or breastfeeding
* COPD exacerbation requiring hospitalization, systemic corticosteroids, or antibiotics within the preceding 3 months
* Musculoskeletal pain, injury, or any other condition that precludes the use of a stationary bike for Cardiopulmonary Exercise Test (CPET)
* Any condition that, in the opinion of the investigator, would compromise participant safety or data integrity
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.